Patents

US 12383588 B2: Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections

Granted
2025-08-12
Filed
2021-05-03 application 17246955
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.

Source: PVGPATDIS, file of 2026-04-10 (ipg250812.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Nemours Foundation 18 patentsUS company or organizationWilmington, DETHE NEMOURS FOUNDATION State business registration EXACT high confidence: identical full name and state
THE NEMOURS FOUNDATION Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Kenneth Andrew ALEXANDEROrlando, FL2PVGPATDIS, file of 2026-04-10
Joseph MazarOrlando, FL2PVGPATDIS, file of 2026-04-10
Tamarah Jeanette WestmorelandOrlando, FL2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/768PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K16/2896PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N2770/24132PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-05-04Assignment
Assignment of assignor's interest
ALEXANDER, KENNETH ANDREW signed 2021-04-05
FINKEL, TERRI HELMAN signed 2021-04-05
MAZAR, JOSEPH signed 2021-04-05
WANG, JIANGFANG signed 2021-04-05
ROSADO, AMY LYNN signed 2021-04-06
WESTMORELAND, TAMARAH JEANETTE signed 2021-04-16
THE NEMOURS FOUNDATION WILMINGTON, DE56126/535ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.